Neurology
Found 3 results
Filters: Keyword is Immunosuppressive Agents  [Clear All Filters]
2022
Zinger N, Ponath G, Sweeney E, Nguyen TD, Lo CHung, Diaz I, Dimov A, Teng L, Zexter L, Comunale J et al..  2022.  Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions.. Neurol Neuroimmunol Neuroinflamm. 9(2)
2017
Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.  2017.  No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.
2013
Reardon J, Perumal JS.  2013.  Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.. Drug Des Devel Ther. 7:1187-93.